The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Takimoto Chris H since 2019.
This trader's CIK number is 1743780.
At the time of last reporting, Takimoto Chris H was the CHIEF MEDICAL OFFICER of Igm Biosciences, Inc.. (stock ticker symbol IGMS).
Also see all insider trading activities at Igm Biosciences, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | IGMS | 0 | $0 | 8,481 | $83,361 | 0 | $0 |
2023 | IGMS | 0 | $0 | 4,207 | $56,379 | 0 | $0 |
2022 | IGMS | 0 | $0 | 7,245 | $138,592 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | FTSV | 0 | $0 | 79,195 | $7,556,786 | 79,195 | $897,675 |
2019 | FTSV | 0 | $0 | 63,163 | $1,345,678 | 60,000 | $120,900 |
1. Igm Biosciences, Inc. (IGMS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-09-13 | IGMS | Sale | 1,487 | 11.54 | 17,158 |
2024-06-14 | IGMS | Sale | 1,570 | 7.58 | 11,892 |
2024-03-13 | IGMS | Sale | 2,889 | 9.88 | 28,528 |
2024-03-14 | IGMS | Sale | 2,535 | 10.17 | 25,783 |
2023-11-29 | IGMS | Sale | 1,180 | 6.21 | 7,331 |
2023-05-23 | IGMS | Sale | 1,259 | 12.65 | 15,930 |
2023-03-14 | IGMS | Sale | 1,768 | 18.73 | 33,118 |
2022-12-16 | IGMS | Sale | 5,430 | 19.07 | 103,533 |
2022-11-23 | IGMS | Sale | 877 | 21.68 | 19,016 |
2022-05-24 | IGMS | Sale | 938 | 17.10 | 16,043 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-04-01 | FTSV | Option Ex | 79,195 | 11.34 | 897,675 |
2020-04-01 | FTSV | Sale | 79,195 | 95.42 | 7,556,786 |
2019-12-10 | FTSV | Sale | 10,000 | 35.00 | 350,000 |
2019-12-10 | FTSV | Option Ex | 10,000 | 2.02 | 20,150 |
2019-12-09 | FTSV | Sale | 10,000 | 30.00 | 300,000 |
2019-12-09 | FTSV | Option Ex | 10,000 | 2.02 | 20,150 |
2019-08-16 | FTSV | Sale | 663 | 6.36 | 4,216 |
2019-05-03 | FTSV | Option Ex | 8,000 | 2.02 | 16,120 |
2019-05-03 | FTSV | Sale | 8,000 | 17.99 | 143,952 |
2019-04-04 | FTSV | Option Ex | 8,000 | 2.02 | 16,120 |
2019-04-04 | FTSV | Sale | 8,000 | 16.39 | 131,104 |
2019-03-04 | FTSV | Sale | 8,000 | 16.94 | 135,552 |
2019-03-04 | FTSV | Option Ex | 8,000 | 2.02 | 16,120 |
2019-02-19 | FTSV | Sale | 2,500 | 15.05 | 37,622 |
2019-02-04 | FTSV | Sale | 8,000 | 14.86 | 118,872 |
2019-02-04 | FTSV | Option Ex | 8,000 | 2.02 | 16,120 |
2019-01-04 | FTSV | Option Ex | 8,000 | 2.02 | 16,120 |
2019-01-04 | FTSV | Sale | 8,000 | 15.54 | 124,360 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Takimoto Chris H (CHIEF MEDICAL OFFICER of Igm Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.